Inheritest Carrier Screen is part of a comprehensive offering for preconception to prenatal and from screening to diagnosis. Whether it’s clinical testing or complex genetics, Labcorp can fully support your practice to save time and optimize patient care.
“The primary goal of carrier screening is to facilitate informed reproductive decision making by identifying those [families] at risk of having an affected child with an (autosomal or X-linked) recessive disorder.”1
Inheritest provides carrier screening for more than 500 genes in a variety of panels designed to meet the evolving needs of your patients and your practice, throughout the entire reproductive journey.
The need for more equitable screening for every patient is becoming clear. In a recent Practice Resource, the American College of Medical Genetics and Genomics (ACMG) recommends that:
“Carrier screening paradigms should be ethnic and population neutral and more inclusive of diverse populations...”4
The American College of Obstetricians and Gynecologists (ACOG) states that carrier screening for spinal muscular atrophy (SMA), in addition to cystic fibrosis (CF), “should be offered to all women who are considering pregnancy or are currently pregnant.”5
Everyone carries 3 to 5 mutations that could cause a genetic disorder6
Approximately 1 to 2% of all couples are at risk for having a child affected with a severe recessive genetic disorder7
People may not know their family history or ethnic background8
The absence of family history for genetic disease is not an indicator of decreased risk for having an affected child. For example, more than 80% of infants with CF are born to families with no prior family history.9
Call 800-848-4436 (toll-free within the US)